CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $122,487
- in 1 filing, $122K under 10b5-1 plans
Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-14 | Mossler Mark Chief Accounting Officer | Exercise or conversion | +9,420 | 75,184 | ||
| 2026-02-14 | Mossler Mark Chief Accounting Officer | Shares withheld for taxes | −3,268 | $1.89 | $6K | 71,916 |
| 2026-02-13 | Mossler Mark Chief Accounting Officer | Grant or award | +56,980 | 75,184 | ||
| 2025-02-14 | Mossler Mark Chief Accounting Officer | Shares withheld for taxes | −1,586 | $3.18 | $5K | 18,204 |
| 2024-02-14 | Mossler Mark Chief Accounting Officer | Grant or award | +18,290 | 19,790 | ||
| 2024-02-14 | Mossler Mark Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +27,430 | 27,430 |
Page 1 of 1 · 6 trades